1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So it works quite well as a VEGFR inhibitor and it is de-risked in that sense.
The Brighterside of News on MSN
New study reveals why some brain cells resist Alzheimer's and dementia
In Alzheimer’s disease and other dementias, a protein called tau can pile up inside brain cells and form toxic clumps. Those ...
"Providing clarity around modern statistical methods will help sponsors bring more cures and meaningful treatments to ...
Gene regulation is far more predictable than previously believed, scientists conclude after developing the deep learning ...
Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia February 3, 2026 10:30 ...
Data-driven AI systems increasingly influence our choices, raising concerns about autonomy, fairness, and accountability. Achieving algorithmic autonomy requires new infrastructures, motivation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results